Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
92.29
+4.49 (5.11%)
Mar 4, 2026, 2:20 PM EST - Market open

Mirum Pharmaceuticals Revenue

In the year 2025, Mirum Pharmaceuticals had annual revenue of $521.31M with 54.74% growth. Mirum Pharmaceuticals had revenue of $148.93M in the quarter ending December 31, 2025, with 49.81% growth.

Revenue (ttm)
$521.31M
Revenue Growth
+54.74%
P/S Ratio
10.46
Revenue / Employee
$1,401,376
Employees
372
Market Cap
5.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025521.31M184.42M54.74%
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics1.73B
Caris Life Sciences812.03M
Rhythm Pharmaceuticals189.76M
Protagonist Therapeutics46.02M
CG Oncology4.04M
CRISPR Therapeutics AG3.51M
Revenue Rankings

MIRM News

More News